Dr. Tomayko directs the Yale Immunobullous Clinic. Upon consultation requests from colleagues, Dr. Tomayko evaluates individuals with complex cutaneous autoimmune and inflammatory disorders such as pemphigus, pemphigoid, epidermolysis bullosa acquisita, atopic dermatitis, vitiligo, alopecia areata and psoriasis. She employs a range of treatment modalities, including the systemic immunomodulators rituximab, intravenous immunoglobulin, omalizumab, dupilumab and ustekinumab, targeted “biologic” agents mycophenolate mofetil, azathioprine and methotrexate and phototherapy. She also performs surgical excisions of skin cancers and skin lesions. Dr. Tomayko is an attending physician at Yale Dermatology Associates, Yale-New Haven Hospital and Yale Health.